{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:56Z","timestamp":1772165696886,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immune thrombocytopenia (ITP) is an acquired disorder characterised by a low platelet count due to immune-mediated destruction and impaired platelet production. Here we report a rare case of primary cytomegalovirus (CMV) infection followed by thrombocytopenia after renal transplantation (RT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 24-year-old male patient with end-stage kidney disease secondary to hereditary focal segmental glomerulosclerosis was treated with peritoneal dialysis and received ABO-compatible living-related RT from his aunt. Nine months after the RT, the patient was diagnosed with primary CMV infection. After initiating treatment for primary CMV infection, the patient developed thrombocytopenia. After excluding other diseases or drugs that may cause thrombocytopenia, the patient was finally diagnosed with ITP, administered prednisolone (PSL), and started on\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      eradication therapy. Tapering the PSL dose was difficult, but thrombopoietin receptor agonists (TPO-RAs) were effective.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this case, the patient was diagnosed with ITP, and other causes of thrombocytopenia after RT were successfully ruled out. This case report demonstrates that RT recipients can develop ITP after CMV infection, and, in such cases, TPO-RAs may be an attractive option as a second-line therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-023-03385-x","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T08:01:37Z","timestamp":1699862497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune thrombocytopenia secondary to primary cytomegalovirus infection after renal transplantation treated with a thrombopoietin receptor agonist: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Tomohiro","family":"Takehara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunobu","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Nawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Himuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"3385_CR1","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3:3829\u201366.","journal-title":"Blood Adv"},{"key":"3385_CR2","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","volume":"113","author":"DB Cines","year":"2009","unstructured":"Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113:6511\u201321.","journal-title":"Blood"},{"key":"3385_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2141.2009.07714.x","volume":"146","author":"D DiMaggio","year":"2009","unstructured":"DiMaggio D, Anderson A, Bussel JB. Cytomegalovirus can make immune thrombocytopenic purpura refractory. Br J Haematol. 2009;146:104\u201312.","journal-title":"Br J Haematol"},{"key":"3385_CR4","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/S0272-6386(99)70173-3","volume":"33","author":"K McLaughlin","year":"1999","unstructured":"McLaughlin K, Cruickshank M, Hollomby D, Jevnikar A, Muirhead N. Idiopathic thrombocytopenia after cytomegalovirus infection in a renal transplant recipient. Am J Kidney Dis. 1999;33:e6.","journal-title":"Am J Kidney Dis"},{"key":"3385_CR5","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/imj.13181","volume":"46","author":"JD Simpson","year":"2016","unstructured":"Simpson JD, Matthews GV, Brighton TA, Joseph JE. Cytomegalovirus-associated thrombocytopenia treated with thrombopoietin receptor agonist. Intern Med J. 2016;46:1096\u20139.","journal-title":"Intern Med J"},{"key":"3385_CR6","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.2169\/internalmedicine.51.7193","volume":"51","author":"T Sugioka","year":"2012","unstructured":"Sugioka T, Kubota Y, Wakayama K, Kimura S. Severe steroid-resistant thrombocytopenia secondary to cytomegalovirus infection in an immunocompetent adult. Intern Med. 2012;51:1747\u201350.","journal-title":"Intern Med"},{"key":"3385_CR7","first-page":"139","volume":"15","author":"F Abbasi","year":"2021","unstructured":"Abbasi F, Kaydani GA, Tahannezhad Z, Nakhaie M, Asnafi AA, Moradi M. Prevalence of Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV) Subclinical Infection in Patients with Acute Immune Thrombocytopenic Purpura (ITP). Int J Hematol Stem Cell Res. 2021;15:139\u201344.","journal-title":"Int J Hematol Stem Cell Res"},{"key":"3385_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1365-2141.2009.08064.x","volume":"149","author":"A Papagianni","year":"2010","unstructured":"Papagianni A, Economou M, Tsoutsou E, Athanassiou-Metaxa M. CMV-related immune thrombocytopenic purpura or CMV-induced thrombocytopenia? Br J Haematol. 2010;149:454\u20135.","journal-title":"Br J Haematol"},{"key":"3385_CR9","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1093\/ndt\/12.11.2436","volume":"12","author":"TR Orchard","year":"1997","unstructured":"Orchard TR, Neild GH. Immune thrombocytopenic purpura presenting in an immunosuppressed patient after renal transplantation. Nephrol Dial Transplant. 1997;12:2436\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"3385_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12882-018-0868-7","volume":"19","author":"RM Rashid","year":"2018","unstructured":"Rashid RM, Nabi Z, Ansari AZ, Qaiser Q-A. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy. BMC Nephrol. 2018;19:69.","journal-title":"BMC Nephrol"},{"key":"3385_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/bjh.12869","volume":"166","author":"H Frederiksen","year":"2014","unstructured":"Frederiksen H, Maegbaek ML, N\u00f8rgaard M. Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study. Br J Haematol. 2014;166:260\u20137.","journal-title":"Br J Haematol"},{"key":"3385_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/ndt\/gfaa219","volume":"37","author":"J Malyszko","year":"2022","unstructured":"Malyszko J, Basak G, Batko K, Capasso G, Capasso A, Drozd-Sokolowska J, et al. Haematological disorders following kidney transplantation. Nephrol Dial Transplant. 2022;37:409\u201320.","journal-title":"Nephrol Dial Transplant"},{"key":"3385_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.trre.2014.03.002","volume":"28","author":"B Kaplan","year":"2014","unstructured":"Kaplan B, Qazi Y, Wellen JR. Strategies for the management of adverse events associated with mTOR inhibitors. Transplant Rev (Orlando). 2014;28:126\u201333.","journal-title":"Transplant Rev (Orlando)"},{"key":"3385_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.critrevonc.2004.12.004","volume":"54","author":"B Zhou","year":"2005","unstructured":"Zhou B, Zhao H, Yang RC, Han ZC. Multi-dysfunctional pathophysiology in ITP. Crit Rev Oncol Hematol. 2005;54:107\u201316.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3385_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5045\/br.2018.53.2.110","volume":"53","author":"MJ Jin","year":"2018","unstructured":"Jin MJ, Kim Y, Choi EM, Shim YJ, Kim HS, Suh JK, et al. Clinical characteristics and treatment courses for cytomegalovirus-associated thrombocytopenia in immunocompetent children after neonatal period. Blood Res. 2018;53:110\u20136.","journal-title":"Blood Res"},{"key":"3385_CR16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1182\/bloodadvances.2017010660","volume":"2","author":"TO Kim","year":"2018","unstructured":"Kim TO, Despotovic J, Lambert MP. Eltrombopag for use in children with immune thrombocytopenia. Blood Adv. 2018;2:454\u201361.","journal-title":"Blood Adv"},{"key":"3385_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1532\/IJH97.04193","volume":"81","author":"Y Tomiyama","year":"2005","unstructured":"Tomiyama Y, Kosugi S. Autoantigenic epitopes on platelet glycoproteins. Int J Hematol. 2005;81:100\u20135.","journal-title":"Int J Hematol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03385-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03385-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03385-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T08:05:42Z","timestamp":1699862742000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03385-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3385"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03385-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3106221\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"25 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written and informed consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images were obtained from the patient. A copy of the written consent form is available for review from the journal editor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"336"}}